Scapho 150mg Injection

Scapho 150mg Injection belongs to the monoclonal antibody category, containing the active ingredient Secukinumab. It treats moderate to severe plaque psoriasis, psoriatic arthritis and axial spondyloarthritis. Plaque psoriasis is a skin condition caused due to inflammation. This Injection is an interleukin inhibitor that reduces symptoms like itching, scaling and pain and improves skin clearance. In psoriatic arthritis, Scapho 150mg Injection is either given alone or with Methotrexate to improve the bone and cartilage of the joints and improve your ability to do regular physical activity. In axial spondyloarthritis, this medicine reduces the signs and symptoms and enhances physical function.

Contact your healthcare provider right away if you develop any symptoms of infection while on treatment with this drug. It is not recommended if you are allergic to latex, Scapho 150mg Injection or any of its ingredients, have a history of tuberculosis. Tell your healthcare provider if you have been diagnosed with heart problems, nervous system disorders, ulcerative colitis or Crohn’s disease. During this treatment your physician may monitor your vitals to prevent serious complications. Inform your health care provider if you are about to undergo any dental or surgical procedures. Seek immediate medical attention if you notice dark urine, yellowing of skin, red, scaly patches on skin, unusual bruising, breathing trouble, hives or chest pain.

Ask your health care provider for advice if you are pregnant, think you might be pregnant, planning to have a baby, or breastfeeding your baby. Scapho 150mg Injection is probably unsafe during pregnancy. Tell your doctor before you breastfeed your baby. Your doctor will decide whether you should receive this injection or breastfeed depending on your condition. Discuss effective contraceptive methods with your healthcare provider and consider using them for at least 20 weeks after the last dose of this drug.